SB
PBYI icon

Suntrust Banks’s Puma Biotechnology PBYI Stock Holding History

Suntrust Banks’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,701
Closed -$323K – 1304
2017
Q2 		$323K Sell
3,701
-24,613
-87% -$1.38M ﹤0.01% 1016
2017
Q1 		$1.05M Buy
28,314
+14,023
+98% +$512K 0.01% 642
2016
Q4 		$438K Buy
14,291
+2,991
+26% +$129K ﹤0.01% 1056
2016
Q3 		$757K Buy
+11,300
New +$571K ﹤0.01% 821
2014
Q4 		– Sell
-1,254
Closed -$298K – 1267
2014
Q3 		$298K Buy
+1,254
New +$258K ﹤0.01% 1167
2014
Q2 		– Sell
-12,611
Closed -$1.31M – 1610
2014
Q1 		$1.31M Buy
+12,611
New +$1.48M ﹤0.01% 833

Other funds holding PBYI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return